123i-ibvm
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2007 (NCT00480701)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 123-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- 123i ibvm
- 123i ibvm
- 123i-ibvm
- 123i-ibvm
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00556764 | Early Phase 1 (Phase 1) | Jul 1, 2007 | Department of Defense, Institute for Neurodegenerative Disorders, University of Oklahoma |
| NCT00480701 | Phase 2 | Feb 1, 2007 | Institute for Neurodegenerative Disorders |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Institute for Neurodegenerative Disorders | Academic/Hospital | 2 | 2 | 2 | 2007 |
| Department of Defense | Government | 1 | 0 | 1 | 2007 |
| University of Oklahoma | Academic/Hospital | 1 | 0 | 1 | 2007 |
3 organizations
Page 1 / 1